Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-01-13

Clinical Trial Update: A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1) [Phase 2, Phase 3]

View source ↗

Summary

Status update on the DIAMOND 1 pivotal safety and efficacy study of OCS-01 Eye Drops for diabetic macular edema, with the trial currently in Phase 2/3 and liste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OCS-01 Eye Drops (OCS-01)

Snippet

Sponsor: Oculis | Conditions: Diabetic Macular Edema | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING